MODIFIED ANGIOGRAPHIC INJECTOR AND SYRINGE— 510(k) K902221

Substantially Equivalent

Mallinckrodt Group, Inc.

FDA 510(k) clearance K902221 for MODIFIED ANGIOGRAPHIC INJECTOR AND SYRINGE, Substantially Equivalent on 1990-08-08. Applicant: Mallinckrodt Group, Inc..

Clearance details

Applicant: Mallinckrodt Group, Inc.
Product code: Code DXT
Advisory panel: Cardiovascular
Date received: 1990-05-17
Decision date: 1990-08-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cincinnati, OH, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DXT

product code DXT

Death: 39
Injury: 242
Malfunction: 463
Other: 3
Total: 747

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.